Drugs / Lithium orotate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07459959 | Oct 2026 → Jun 2029 expected | Alzheimer disease | Johns Hopkins University | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lithium orotate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07459959 ↗ |
| Known as | LiO | “Lithium orotate (LiO) oral capsules, over-encapsulated to match placebo.” NCT07459959 ↗ |
| Route | Oral | “Lithium orotate (LiO) oral capsules” NCT07459959 ↗ |